“The addition of an antioxidant “cocktail,” comprising vitamins E and C, β-carotene, and selenium, for participants on simvastatin and niacin (SNA) therapy, resulted in a significant blunting of the apoA1 and HDL2c response compared with those on lipid-lowering drugs alone (SN).”